LabCorp’s LH continued efforts to expand to high-growth opportunity areas and net savings from the ongoing LaunchPad initiative buoy optimism. Yet, the current economic uncertainty, along with a ...
After more than two years of pandemic-driven growth, Labcorp is shipping off its clinical development arm as a standalone, public company. The spinoff—for now, dubbed the “clinical development ...
Laboratory Corporation of America Holdings LH or LabCorp has been gaining from strength in its Covance Drug Development business. The company’s acquisitions of Ovia Health and Personal Genome ...
Labcorp Holdings Inc. LH, or Labcorp, is slated to report its first-quarter 2025 results on April 29, before the opening bell. The renowned laboratory service provider reported adjusted earnings of $3 ...
On May 17, we issued an updated research report on LabCorp (NYSE:LH) . The stock carries a Zacks Rank #3 (Hold). This Burlington, NC-based healthcare diagnostics company, providing comprehensive ...
Healthcare diagnostics company Laboratory Corporation of America HoldingsLH or LabCorp successfully continues to expand through acquisition strategy. Apart from huge buyouts like Covance, the company ...
Nonprofit health system Ascension has inked a strategic relationship with clinical laboratory network Labcorp, in a deal that should expand its testing capabilities. Under the terms of the deal, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback